SmallCapReview.com has been a leading site for information on small cap stocks, penny stocks and microcaps since 1999.
Augme Technologies (OTCBB: AUGT) $4.50. Today announced that it expects to report revenue in excess of $1.0 million for its fourth fiscal quarter, which ended February 28, 2011. This represents a sequential increase in recognizable revenue of approximately 23% relative to third quarter reported revenue of $853,161. In addition, deferred revenue, which is recognized over the period of contract performance of typically one year, increased to over $1.0 million at the end of the fourth quarter, from $409,160 on November 30, 2010, a sequential increase of over 64%. Combined recognizable and deferred sales exceeded $2.1 million in the most recent fourth fiscal quarter, an increase of over 68% when compared with recognizable and deferred sales of $1,262,259 in the third fiscal quarter.
What They Do: Augme Technologies provides strategic services and mobile technology to leading consumer and healthcare brands.
ChromaDex Corporation (OTCBB: CDXC) $1.95. Today announced along with Bruker Optics, a co-development and co-marketing agreement that will promote a new approach to dietary supplement testing. The collaboration will capitalize on the extensive phytochemical and botanical reference standard capabilities of ChromaDex and will initially focus on the near infrared spectrometer (NIR) technology created by Bruker Optics. The parties anticipate extending the relationship to include other Bruker analytical technologies.
Through this collaboration, a dietary supplement producer will have the opportunity to obtain the in-house capabilities of a contract laboratory without the associated start-up costs. The system enables the manufacturer to not only quickly and accurately perform raw material identity testing, but also to determine if any adulteration has taken place. This new approach is accomplished by existing staff utilizing a Bruker NIR unit located in the manufacturer's facility.
What They Do: Bruker Corporation is a leading provider of high-performance scientific instruments and solutions for molecular and materials research, as well as for industrial and applied analysis.
Xtra-Gold Resources (OTCBB: XTRG) $1.87. Today announced the completion of the first 12 diamond core holes (#KBDD11105 to #KBDD11116) totaling 2,589 metres from the current 20,000 m drill program at its wholly-owned Kibi Gold Trend Project, located in the Kibi - Winneba greenstone belt ("Kibi Gold Belt"), in Ghana, West Africa.
Visible Gold ("VG") was observed in nine (9) out of the 12 holes; with seven (7) holes yielding multiple visible gold occurrences. Core samples for the first eight (8) of these holes have been submitted to the ALS Chemex laboratory in Kumasi, Ghana, and the samples for the remaining four (4) holes are expected to be submitted to the laboratory by the end of the week. The reader is cautioned that the presence of visible gold mineralization does not necessarily equate to significant concentrations of gold and there is no assurance that the assay results of the samples from these drill holes will yield significant gold grades.
What They Do: Xtra-Gold is a gold exploration company with a substantial land position in the Kibi greenstone belt ('Kibi Gold Belt') located in Ghana, West Africa.
About SmallCapReview
Copyright SmallCapReview. SmallCapReview.com is a leading site for news on small-caps, penny stocks and microcaps. SmallCapReview has built a loyal opt-in following for their investor products by providing a newsletter at no cost, sent to subscribers, highlighting select stocks in play, to register visit www.SmallCapReview.com.
